Moscow, 28 May 2015 - Public Joint Stock Company "Pharmstandard" (LSE: PHST, RTS: PHST RU) (the "Company") announces the decision of its Board of Directors with respect to the Tender Offer made by Augment Investments Limited ("Augment") to holders of Global Depository Receipts (“GDRs”) representing Ordinary Shares of the Company.
 
On 14 May 2015 the Company was informed by Augment about the Tender Offer. At a meeting of the Company's Board of Directors on 28 May 2015, the Board of Directors considered the Tender Offer and approved the engagement of an independent financial advisor (LLC “Renaissance Capital – FK”) to provide advice to the Company in connection with the Tender Offer.